Use of the renin inhibitor aliskiren.

The result of renin inhibition on coronary disease progression has not been investigated. Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Medical and Health Analysis Institute, Adelaide, Australia, and colleagues conducted a study to determine if renin inhibition with aliskiren would sluggish progression of coronary atherosclerosis in patients whose blood pressure was considered optimally controlled to current treatment targets. The randomized, multicenter trial weighed against placebo in 613 individuals with coronary artery disease aliskiren, systolic blood circulation pressure between 125 and 139 mm Hg , and 2 additional cardiovascular risk elements. The trial was carried out at 103 educational and community hospitals in European countries, Australia, and North and South America .We chose the finance sector since it has a huge proportion of female employees at all amounts, with many different types of employment ranging from full-time to informal, and it is part of a global industry, Dr Mayson said. Contact: Ph: +61 3 9904 4362.

AARP tracks upcoming Senate vote on Idaho Wellness Freedom Act With the Idaho State Senate expected to vote today on the ill-conceived Idaho Health Freedom Act , a bill that could wreak havoc on the state’s healthcare system, AARP has announced it will make the vote a part of it’s ‘accountability vote’ efforts. IDAHO Monday, February 22, 2010 Dear Senator: On behalf of our 180,000 members in Idaho, I needed to revise you on some of AARP’s activities that relate to our legislative agenda. Our members value ensuring health care is more affordable and accessible deeply, traveling down soaring prescription drug costs, protecting Medicare and Medicaid, and tackling skyrocketing medical health insurance premiums.